References
- Greer A, Haddad N G, Dawes J, Johnstone F D, Calder A A. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynecol 1989; 96: 978–82
- Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1992; 79: 19–26
- Balduyck M, Davril M, Mizon C, Smyrlaki M, Hayem A, Mizon J. Human urinary protease inhibitor: inhibitory properties and interaction with bovine trypsin. Biol Chem Hoppe-Seyler 1985; 366: 9–14
- Ödum L, Hansen-Nord G, Byrjalsen I. Human inter α trypsin inhibitor and immunologically related inhibitors investigated by quantitative immuno-electrophoresis. II. Pathological conditions. Clin Chim Acta 1987; 162: 189–98
- Faarvang H J. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta Endocrinol 1959; 31: 117–22
- Kudo Y, Egashira T, Yamanaka Y. Protective effect of uli-nastatin against liver injury caused by ischemia-reperfusion in rats. Japan J Pharmacol 1992; 60: 239–45
- Ohnishi H, Kosuzume H, Nobuhara M. Pharmacological activities of a trypsin inhibitor, Urinastatin (Miraclid). Pharmacometrics 1986; 31: 663–75
- Ohlsson K, Rosengren M. Radioimmunological quantita-tion of urinary trypsin inhibitor in normal blood and urine. Bio-Chem Hoppe Seyler 1989; 370: 1157–61
- Harlan J D. Neutrophil-mediated vascular injury. Acta Med Scand Suppl 1987; 715: 123–9
- Balduyck M, Mizon J. Inter-alpha-trypsin inhibitor and its plasma and urine derivatives. Ann Biol Clin Paris 1991; 49: 273–81
- Ogawa M, Nishibe S, Mori T, Neumann S. Effect of human urinary trypsin inhibitor on granulocyte elastase activity. Res Commun Chem Pathol Pharmacol 1987; 55: 271–4
- Nishijima J, Hiraoka N, Murata A, et al. Protease inhibitors (Gabexate mesylate and ulinastatin) stimulate intracel-lular chemiluminescence in human neutrophils. J Leukoc -Biol 1992; 52: 262–8
- Roberts J M, Taylor R N, Music T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
- Abe M, Morita I, Murota S. A new in vitro method using Fura-2 for the quantification of endothelial cell injury. Prostaglandins Leukot Essent Fatty Acids 1988; 34: 69–74
- Jonsson-Berling B M, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest 1991; 51: 549–57